Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References and Suggested Readings
Alessi A, Farrell MB, Grabher JB, et al. Nuclear cardiology study guide. Reston, VA: SNM; 2010.
Andreoli TE, Bennett JC, et al. Cecil essentials of medicine. 5th ed. Philadelphia, PA: WB Saunders Company; 2001.
CDC. http://www.cdc.gov/Features/dsMenTop10Cancers/. Accessed 20 Feb 2012
Chen W, Li G, Parsons M, et al. Clinical significance of incidental focal versus diffuse thyroid uptake on FDG-PET imaging. PET Clin. 2007;2:321–9.
Christian PE, Bernier DR, Langan JK. Nuclear medicine and PET: technology and techniques. 5th ed. St. Louis, MO: Mosby; 2004.
Goldberger LA. Clinical electrocardiography: a simplified approach. 7th ed. St. Louis, MO: Mosby Elsevier; 2006.
Hickeson M, Abikhzer G. Review of physiologic and pathophysiologic sources of fluorodeoxyglucose uptake in the chest wall on PET. PET Clin. 2011;6(3):339–64.
Hu MI, Vassilopoulou-Sellin R, Lustig R, Lamont JP. Thyroid and parathyroid cancers. In: Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ, editors. Cancer management: a multidisciplinary approach. 11th ed. Manhasset, NY: CMP Medica; 2008.
Jadver H, Parker JA. Clinical PET and PET/CT. London: Springer; 2005.
Lilly.http.newsroom.lilly.com. Accessed 9 April 2012
Lin CE, Alavi A. PET and PET/CT. A clinical guide. 2nd ed. New York, NY: Thieme; 2009.
Mazzaferri EL, Robbins RJ, Spencer CA, et al. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab. 2003;88(4):1433–41.
Mittra E, Quon A. Positron emission tomography/computed tomography: the current technology and applications. Radiol Clin North Am. 2009;47:147–60.
Munro HB. Statistical methods for health care research. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005.
Thyroid cancer. http://en.wikipedia.org/wiki/Thyroid_cancer. Accessed 15 Feb 2012
Vallabhajosula S, Killeen R, Osborne J. Altered biodistribution of radiopharmaceuticals: role of radiochemical/pharmaceutical purity, physiological, and pharmacologic factors. Semin Nucl Med. 2010;40:220–41.
Vallabhajosula S, Solnesn L, Vallabhajosula B. Broad overview of positron emission tomography radiopharmaceuticals and clinical applications: what is new? Semin Nucl Med. 2011;41:246–64.
Wahl LR, Jacene H. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50 Suppl 1:122s–50s.
Wahl RL. Principles and practice of PET and PET/CT. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2009.
Zanzonico P. Routine quality control of clinical nuclear medicine instrumentation: a brief review. J Nucl Med. 2008;49:1114–31.
Zaret BL, Beller GA. Clinical nuclear cardiology: state of the art and future directions. 3rd ed. Philadelphia, PA: Mosby; 2005.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Moniuszko, A., Sciuk, A. (2013). Practice Test # 4: Bonus Questions. In: PET and PET/CT Study Guide. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-2287-7_5
Download citation
DOI: https://doi.org/10.1007/978-1-4614-2287-7_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-2286-0
Online ISBN: 978-1-4614-2287-7
eBook Packages: MedicineMedicine (R0)